seobhushan

1
Next Generation Sequencing Market is Projected to
grow at a CAGR 21.2 by 2027
2
Key Insights from Next Generation Sequencing
Market

• The Next generation sequencing market is
  estimated to procure steady growth driven by
  robust application of NGS tools in the medical
  research field and clinical diagnosis. Growing
  usage of NGS techniques by biopharmaceutical and
  pharmaceutical firms along with prevalence of
  chronic illnesses like diabetes and cancer is
  giving a boost to technology demand. These firms
  are investing in RD activities to create
  alternative solutions and make personalized
  medicines for different diseases.
• Next generation sequencing methods are used for
  studying genomes and identifying problems caused
  in genes due to disease development. Businesses
  have created NGS library preparation kits
  automated data analysis tools, and sequencing
  instruments for the studying of genes. Companies
  operating in the NGS market are working on new
  technologies and products. For example, in 2019,
  Agilent Technologies announced a next generation
  sequencing library preparation system made to run
  complex DNA sequencing assays easily with a
  button press.
• In terms of product type, the next generation
  sequence services segment is likely to register a
  CAGR of around 20 over the forecast period.
  These services are extensively available in areas
  such as RNA sequencing, cancer analysis services,
  metagenomics solutions, whole genome sequencing,
  and oligo synthesis.

3
Continued

• Based on type, the target sequencing section is
  anticipated to register around USD 700 million in
  2020 owing to rising demand for personalized
  medicines. The targeted sequencing type correctly
  measures individuals gene pool which can be used
  for personalized medicines. With the variation of
  genetic makeup from individual to individual, the
  concentration of drugs meant for consumption also
  varies.
• With respect to technology, sequencing by
  synthesis segment is likely to witness
  approximately 20.6 CAGR in the upcoming years.
  Sequencing by synthesis enables accurate and
  quick DNA analysis, and is a cost-effective
  option. The whole human genome can be sequenced
  in a few hours given to the availability of
  technologically advanced equipment.
• In terms of end-use, the demand from academic
  institutes and research centers accounted for
  above USD 2.5 billion in 2020. This can be
  credited to growing research efforts on genomic
  aspects with the use of NGS methods. Research
  institutes receive funds from governments to
  promote advancements in drug discovery processes.
  In this way, academic institutes and research
  laboratories are well-equipped with modern NGS
  devices.

4

Latest Research Report On Next Generation
Sequencing Market_at_ https//www.gminsights.com/ind
ustry-analysis/next-generation-sequencing-market
Request for a sample of this research report
_at_ https//www.gminsights.com/request-sample/detail
/3247
5
Major Companies in Next Generation Sequencing
Market

• 10X Genomics
• Agilent Technologies, Inc.
• BGI
• Bio-Rad Laboratories
• F Hoffmann-La Roche
• GenapSys Inc.
• Illumina, Inc.
• NanoString Technologies, Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California, Inc.
• PerkinElmer Inc.
• Qiagen
• Thermo Fisher Scientific

6
Industry Coverage

7
Stay In Touch Website www.gminsights.com Soci
al Media